As such, the panel referred to the Centre for Innovation in Regulatory Science (CIRS) data showing the TGAs median approval time of 391 days in 2013fourth out of the six regulators assessed: FDA (USA), Pharmaceuticals and Medical Devices Agency (PMDA, Japan), Health Canada, EMA (EU) and Swissmedic (Switzerland) (median approval time 304, 342, 350, 478 and 511 days, respectively) [12]
The ease of storage and fast, mess-free administration make it a realistic option for those who want to maintain consistency in research protocols without interrupting the flow of daily life
If the provided concentrations of the actives are high enough, and the topical product is repeatedly applied as a leave-on product, like in the current study, we believe that sufficient amounts of actives reach the hair bulb
The Australian government banned the prescribing and dispensing of compounded semaglutide in October 2024 due to safety concerns, including reports of inconsistent potency
[2] Rachael Ajmera, MS, RD
This is our most targeted body recomposition peptide stack, and we prescribe it only when your labs and goals justify both compounds working in parallel